
LFST Stock Forecast & Price Target
LFST Analyst Ratings
Bulls say
LifeStance Health Gr is in an advantageous position in the mental healthcare industry due to its unique hybrid model and strong financials. With a high percentage of revenue from Commercial plans, the company is able to generate higher rates and has lower exposure to government payers. However, competition from other health-tech companies and potential risks such as changes in laws and regulations, and technological advancements should also be considered in its outlook. Despite these challenges, LFST is expected to experience long-term revenue growth and has a strong management team focused on quality care and business strategy, making it a top pick in the sector.
Bears say
LifeStance Health Gr is facing competition from a number of other health-tech companies that focus on mental health, including Talkspace(TALK, Not Rated) and Teladoc's BetterHelp (TDOC, Neutral), general tele-health companies, including Amwell (AMWL, Neutral)and LifeMD (LFMD, Buy, $10 PT) and a significant exposure to reimbursement rates and the possibility of rate declines can lead to a headwind for LFST. Additionally, the company relies heavily on third-party suppliers, making it vulnerable to disruption and the high EV / 12.6x 2027E EBITDA multiple is concerning given the average multiple for its subsector being just 8.9x.
This aggregate rating is based on analysts' research of LifeStance Health Group and is not a guaranteed prediction by Public.com or investment advice.
LFST Analyst Forecast & Price Prediction
Start investing in LFST
Order type
Buy in
Order amount
Est. shares
0 shares